List of Tables
Table 1. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs), Product Types and Applications
Table 12. Global Key Manufacturers of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Region (K Units), 2021–2026
Table 18. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Region (2021–2026)
Table 19. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Region (K Units), 2027–2032
Table 20. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Region (2027–2032)
Table 21. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Region (2021–2026)
Table 23. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Region (2027–2032)
Table 25. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2021–2026
Table 27. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2027–2032
Table 28. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2021–2026
Table 32. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2027–2032
Table 33. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2021–2026
Table 42. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2027–2032
Table 43. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units) by Type (2021–2026)
Table 51. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units) by Type (2027–2032)
Table 52. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Type (2021–2026)
Table 53. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Type (2027–2032)
Table 54. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Type (2021–2026)
Table 57. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Type (2027–2032)
Table 58. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units) by Application (2021–2026)
Table 61. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units) by Application (2027–2032)
Table 62. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Application (2021–2026)
Table 63. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Application (2027–2032)
Table 64. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Application (2021–2026)
Table 67. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Application (2027–2032)
Table 68. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Price (US$/Unit) by Application (2027–2032)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bristol Myers Squibb Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. AbbVie Company Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AbbVie Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Hetero Company Information
Table 86. Hetero Description and Business Overview
Table 87. Hetero Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hetero Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 89. Hetero Recent Developments/Updates
Table 90. Zydus Company Information
Table 91. Zydus Description and Business Overview
Table 92. Zydus Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Zydus Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 94. Zydus Recent Developments/Updates
Table 95. Natco Pharma Company Information
Table 96. Natco Pharma Description and Business Overview
Table 97. Natco Pharma Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Natco Pharma Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 99. Natco Pharma Recent Developments/Updates
Table 100. Cipla Company Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Cipla Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 104. Cipla Recent Developments/Updates
Table 105. Simcere Pharmaceutical Company Information
Table 106. Simcere Pharmaceutical Description and Business Overview
Table 107. Simcere Pharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Simcere Pharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 109. Simcere Pharmaceutical Recent Developments/Updates
Table 110. Chia Tai Tianqing Pharmaceutical Company Information
Table 111. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 112. Chia Tai Tianqing Pharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Chia Tai Tianqing Pharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 114. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 115. Qilu Pharmaceutical Company Information
Table 116. Qilu Pharmaceutical Description and Business Overview
Table 117. Qilu Pharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Qilu Pharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 119. Qilu Pharmaceutical Recent Developments/Updates
Table 120. Sino Biopharmaceutical Company Information
Table 121. Sino Biopharmaceutical Description and Business Overview
Table 122. Sino Biopharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sino Biopharmaceutical Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Product
Table 124. Sino Biopharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Distributors List
Table 128. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Customers List
Table 129. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Trends
Table 130. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Drivers
Table 131. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Challenges
Table 132. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs)
Figure 2. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Share by Type: 2025 & 2032
Figure 4. Tofacitinib Product Picture
Figure 5. Upadacitinib Product Picture
Figure 6. Ozanimod Product Picture
Figure 7. Other Product Picture
Figure 8. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Share by Application: 2025 & 2032
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Size (US$ Million), 2021–2032
Figure 15. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales (K Units), 2021–2032
Figure 16. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Average Price (US$/Unit), 2021–2032
Figure 17. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Report Years Considered
Figure 18. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Share by Manufacturers in 2025
Figure 19. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Players: Market Share by Revenue in Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) in 2025
Figure 21. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Country (2021–2032)
Figure 24. North America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Country (2021–2032)
Figure 25. United States Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Country (2021–2032)
Figure 28. Europe Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Country (2021–2032)
Figure 29. Germany Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Region (2021–2032)
Figure 36. China Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Country (2021–2032)
Figure 44. Latin America Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) by Type (2021–2032)
Figure 55. Global Revenue Market Share of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) by Type (2021–2032)
Figure 56. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) by Application (2021–2032)
Figure 58. Global Revenue Market Share of Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) by Application (2021–2032)
Figure 59. Global Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Price (US$/Unit) by Application (2021–2032)
Figure 60. Small Molecules Drugs for Inflammatory Bowel Diseases (IBDs) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
